A separate study found that taurine-upregulated gene 1 (TUG1) regulates the activity of LIMK2b (a splice variant of LIM-kinase 2) by binding to the enhancer of EZH2, thereby mediating chemoresistance in SCLC [1,175]. The gene discussed is EZH2; the disease is small cell lung carcinoma.